{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:25:08Z","timestamp":1786991108314,"version":"build-2736575974"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019533","name":"Moderna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019533","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>With a large proportion of adults in Canada vaccinated against SARS-CoV-2, it is important to identify who remain at risk for severe COVID-19 outcomes after primary vaccination and additional (booster) doses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adults (\u226518 years) who received at least a primary vaccination schedule between December 2020 and March 2023 in Alberta, Canada were identified through population-level administrative data. Factors associated with severe COVID-19 outcomes (COVID-19 related hospitalization or death) were examined using univariable and multivariable Cox proportional hazard models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among those who received a primary vaccination schedule (n\u2009=\u20092,639,731), 0.2% (n\u2009=\u20095,475) had\u2009\u2265\u20091 severe COVID-19 outcome. Factors associated with a greater risk of a severe COVID-19 outcome included older age (\u226565 versus &lt;65 years; unadjusted hazard ratio [95% confidence interval]: 8.83 [8.33\u20139.35]), and living with a higher comorbid burden (severe versus no burden; 32.56 [29.78\u201335.60]) or health condition of interest (1.33 [1.25\u20131.42] to 29.25 [23.14\u201336.99]) such as the relatively common condition of cardiovascular disease (7.01 [6.62\u20137.42]; present in 10.5% of the cohort) and less common condition of dementia (13.96 [12.76\u201315.28]; present in 1.5% of the cohort); male sex was also associated with risk (versus female; 1.07 [1.01\u20131.13]). Results remained significant in fully adjusted analysis, and among those with \u22651 additional vaccination dose (n\u2009=\u20091,580,110).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although primary vaccination and additional doses have dramatically reduced the occurrence of severe COVID-19 outcomes, results showed that continued risk remained for specific groups. Findings can be used to inform decision making, public health strategies, and policy development to protect those who remain at risk of severe COVID-19 outcomes after receipt of a primary vaccination schedule or additional doses, and support Canada\u2019s National Advisory Committee on Immunisation recommendations for specific groups to stay up to date with COVID-19 vaccination to protect against severe COVID-19 outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0354822","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:27:31Z","timestamp":1786987651000},"page":"e0354822","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors associated with severe COVID-19 outcomes among adults with at least a primary vaccination schedule: A retrospective cohort study from Alberta, Canada"],"prefix":"10.1371","volume":"21","author":[{"given":"Sylvia","family":"Aponte-Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huong","family":"Luu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3400-7214","authenticated-orcid":true,"given":"Karen J. B.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Randall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynora","family":"Saxinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa","family":"Rennert-May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenine","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5029-2345","authenticated-orcid":true,"given":"Tyler","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehzad M.","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Mansi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre B.","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott W.","family":"Klarenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"pone.0354822.ref001","author":"World Health Organization"},{"issue":"1","key":"pone.0354822.ref002","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2021.2002083","article-title":"A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson","volume":"18","author":"R Patel","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"20","key":"pone.0354822.ref003","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.2021.19499","article-title":"Association between mRNA vaccination and COVID-19 hospitalization and disease severity","volume":"326","author":"MW Tenforde","year":"2021","journal-title":"JAMA"},{"key":"pone.0354822.ref004","first-page":"24","volume-title":"Guidance on the use of COVID-19 vaccines for 2025 to summer 2026","author":"An advisory committee statement (ACS) National Committee on Immunization (NACI)","year":"2025"},{"issue":"1","key":"pone.0354822.ref005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12979-022-00309-5","article-title":"Aging, inflammaging and immunosenescence as risk factors of severe COVID-19","volume":"19","author":"AM Tizazu","year":"2022","journal-title":"Immun Ageing"},{"issue":"5","key":"pone.0354822.ref006","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/infdis\/jiac453","article-title":"Use of whole-genome sequencing to estimate the contribution of immune evasion and waning immunity on decreasing COVID-19 vaccine effectiveness","volume":"227","author":"ML Lind","year":"2023","journal-title":"J Infect Dis"},{"issue":"11","key":"pone.0354822.ref007","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/jama.2022.2068","article-title":"Association of COVID-19 vaccination with symptomatic SARS-CoV-2 infection by time since vaccination and delta variant predominance","volume":"327","author":"A Britton","year":"2022","journal-title":"JAMA"},{"issue":"15","key":"pone.0354822.ref008","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa2114255","article-title":"Protection of BNT162b2 vaccine booster against Covid-19 in Israel","volume":"385","author":"YM Bar-On","year":"2021","journal-title":"N Engl J Med"},{"issue":"10","key":"pone.0354822.ref009","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3390\/bioengineering9100584","article-title":"Risk factors associated with mortality in hospitalized patients with COVID-19 during the Omicron wave in Brazil","volume":"9","author":"M Colnago","year":"2022","journal-title":"Bioengineering (Basel)"},{"key":"pone.0354822.ref010","unstructured":"Government of Canada. COVID-19 vaccination: vaccination coverage. Government of Canada; [updated 2023 May 05; cited 2026 May 19]. Available from: https:\/\/health-infobase.canada.ca\/covid-19\/vaccination-coverage\/"},{"key":"pone.0354822.ref011","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijid.2022.12.001","article-title":"Risk factors for COVID-19 hospitalization after COVID-19 vaccination: a population-based cohort study in Canada","volume":"127","author":"HA Vel\u00e1squez Garc\u00eda","year":"2023","journal-title":"Int J Infect Dis"},{"key":"pone.0354822.ref012","doi-asserted-by":"crossref","first-page":"100441","DOI":"10.1016\/j.lanepe.2022.100441","article-title":"Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule: a cohort study of 28 million people in France","volume":"19","author":"L Semenzato","year":"2022","journal-title":"Lancet Reg Health Eur"},{"issue":"10","key":"pone.0354822.ref013","article-title":"Factors associated With severe COVID-19 among vaccinated adults treated in US veterans affairs hospitals","volume":"5","author":"AD Vo","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"pone.0354822.ref014","doi-asserted-by":"crossref","first-page":"19","DOI":"10.15585\/mmwr.mm7101a4","article-title":"Risk factors for severe COVID-19 outcomes among persons aged \u226518 years who completed a primary COVID-19 vaccination series - 465 health care facilities, United States, December 2020-October 2021","volume":"71","author":"C Yek","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10313","key":"pone.0354822.ref015","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(21)02316-3","article-title":"Characteristics and risk of COVID-19-related death in fully vaccinated people in Scotland","volume":"398","author":"Z Grange","year":"2021","journal-title":"Lancet"},{"issue":"10360","key":"pone.0354822.ref016","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(22)01656-7","article-title":"Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales","volume":"400","author":"U Agrawal","year":"2022","journal-title":"Lancet"},{"issue":"7","key":"pone.0354822.ref017","doi-asserted-by":"crossref","first-page":"102450","DOI":"10.1016\/j.jiph.2024.05.007","article-title":"Risk factors for COVID-19 hospitalisation after booster vaccination during the Omicron period: a French nationwide cohort study","volume":"17","author":"A Turpin","year":"2024","journal-title":"J Infect Public Health"},{"key":"pone.0354822.ref018","doi-asserted-by":"crossref","first-page":"100816","DOI":"10.1016\/j.lanepe.2023.100816","article-title":"Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales","volume":"37","author":"S Bedston","year":"2023","journal-title":"Lancet Reg Health Eur"},{"issue":"14","key":"pone.0354822.ref019","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jama.2022.17985","article-title":"Incidence of severe COVID-19 illness following vaccination and booster with BNT162b2, mRNA-1273, and Ad26.COV2.S vaccines","volume":"328","author":"JD Kelly","year":"2022","journal-title":"JAMA"},{"key":"pone.0354822.ref020","doi-asserted-by":"crossref","first-page":"126539","DOI":"10.1016\/j.vaccine.2024.126539","article-title":"COVID-19 vaccine effectiveness against severe omicron-related outcomes in children aged 5 to 11 years in Ontario: a Canadian immunization research network (CIRN) study","volume":"44","author":"PP Piche-Renaud","year":"2025","journal-title":"Vaccine"},{"issue":"6","key":"pone.0354822.ref021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0325269","article-title":"Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: impact of variant replacement and waning protection during 10-month follow-up","volume":"20","author":"S Carazo","year":"2025","journal-title":"PLoS One"},{"issue":"10","key":"pone.0354822.ref022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement","volume":"12","author":"EI Benchimol","year":"2015","journal-title":"PLoS Med"},{"key":"pone.0354822.ref023","author":"Statistics Canada","year":"2024"},{"key":"pone.0354822.ref024","volume-title":"Comparison of Alberta population counts between the AHCIP registry and the 2006 census","author":"Y Jin","year":"2009"},{"issue":"12","key":"pone.0354822.ref025","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S2213-2600(21)00380-5","article-title":"COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2\u00b757 million people in Scotland (EAVE II): a prospective cohort study","volume":"9","author":"U Agrawal","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"4","key":"pone.0354822.ref026","doi-asserted-by":"crossref","first-page":"178","DOI":"10.24095\/hpcdp.29.4.05","article-title":"A deprivation index for health planning in Canada","volume":"29","author":"R Pampalon","year":"2009","journal-title":"Chronic Dis Can"},{"key":"pone.0354822.ref027","volume-title":"Cancer data linkage in Manitoba: expanding the infrastructure for research","author":"L Lix","year":"2016"},{"issue":"5","key":"pone.0354822.ref028","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"ME Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"26","key":"pone.0354822.ref029","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1056\/NEJMoa2115624","article-title":"BNT162b2 vaccine booster and mortality due to Covid-19","volume":"385","author":"R Arbel","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0354822.ref030","article-title":"Validity of ICD-10 codes for COVID-19 patients with hospital admissions or ED visits in Canada: a retrospective cohort study","volume":"12","author":"G Wu","year":"2022","journal-title":"BMJ Open"},{"key":"pone.0354822.ref031","doi-asserted-by":"crossref","first-page":"100755","DOI":"10.1016\/j.lanepe.2023.100755","article-title":"Vaccine effectiveness against hospitalisation estimated using a test-negative case-control study design, and comparative odds of hospital admission and severe outcomes with COVID-19 sub-lineages BQ.1, CH.1.1. and XBB.1.5 in England","volume":"35","author":"FCM Kirsebom","year":"2023","journal-title":"Lancet Reg Health Eur"},{"issue":"12","key":"pone.0354822.ref032","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1017\/ice.2022.13","article-title":"The COVID-19 hospitalization metric in the pre- and postvaccination eras as a measure of pandemic severity: a retrospective, nationwide cohort study","volume":"43","author":"NR Fillmore","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"pone.0354822.ref033","first-page":"1887","article-title":"Robust causal inference using directed acyclic graphs: the R package \u201cdagitty\u201d","volume":"45","author":"J Textor","year":"2016","journal-title":"Int J Epidemiol"},{"key":"pone.0354822.ref034","unstructured":"Alberta Health. Health data, research and standards: health research data access. Government of Alberta; [cited 2024 May 24]. Available from: https:\/\/www.alberta.ca\/health-research"},{"key":"pone.0354822.ref035","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2021"},{"issue":"4","key":"pone.0354822.ref036","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1259","article-title":"Immunocompromised individuals are at increased risk of COVID-19 breakthrough infection, hospitalization, and death in the post-vaccination era: a systematic review","volume":"12","author":"J Bytyci","year":"2024","journal-title":"Immun Inflamm Dis"},{"key":"pone.0354822.ref037","author":"World Health Organization","year":"2026"},{"issue":"1","key":"pone.0354822.ref038","doi-asserted-by":"crossref","first-page":"2155250","DOI":"10.1080\/22221751.2022.2155250","article-title":"Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study","volume":"12","author":"K Miyashita","year":"2023","journal-title":"Emerg Microbes Infect"},{"issue":"5","key":"pone.0354822.ref039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286142","article-title":"COVID-19 hospitalisations and all-cause mortality by risk group in Finland","volume":"18","author":"M Summanen","year":"2023","journal-title":"PLoS One"},{"issue":"7","key":"pone.0354822.ref040","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s40121-026-01352-1","article-title":"Severity of COVID-19 omicron variants: a global systematic review","volume":"15","author":"D Malhotra","year":"2026","journal-title":"Infect Dis Ther"},{"issue":"3","key":"pone.0354822.ref041","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcjd.2020.08.106","article-title":"Validity of hospital codes for obesity in Ontario, Canada","volume":"45","author":"KK Clemens","year":"2021","journal-title":"Can J Diabetes"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0354822","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:27:39Z","timestamp":1786987659000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0354822"}},"subtitle":[],"editor":[{"given":"Etsuro","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0354822","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]}}}